Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate

被引:2
|
作者
Dounighi, Naser M. [1 ,3 ]
Shahcheraghi, Fereshteh [1 ]
Razzaghi-Abyaneh, Mehdi [2 ]
Nofeli, Mojtaba [3 ]
Zolfagharian, Hossein [3 ]
机构
[1] Pasteur Inst Iran, Dept Microbiol, POB 13164, Tehran 13164, Iran
[2] Pasteur Inst Iran, Dept Mycol, POB 13164, Tehran 13164, Iran
[3] Agr Res Educ & Extens Org, Razi Vaccine & Serum Res Inst, Dept Human Vaccine & Serum, Karaj, Iran
关键词
Bordetella pertussis; microparticle; whole-cell vaccine; cytokines; humoral immunity; alginate microspheres; ANTIBODY-RESPONSES; EFFICACY; INFANTS; 2-COMPONENT; PROTECTION; DEFENSINS; INFECTION; CHILDREN; ANTIGENS; DELIVERY;
D O I
10.2174/1389201018666170815170515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Effectiveness of the whole-cell pertussis vaccine is apparent, but improvement in the quality of the vaccine is necessary to achieve strong immunogenicity with a low bacterial number content. Method: Inactivated Bordetella pertussis (B. pertussis) cells entrapped microspheres were prepared via an emulsification method and analyzed for morphology, size, size distribution, loading efficiency, loading capacity, release kinetic, in vivo cytokines and antigen specific antibody subclasses. Results: Bordetella pertussis encapsulated microspheres exhibited a smooth surface and spherical shape, mean particle size 151.1 mu m, size distribution index 0.43, loading efficiency 89.6%, loading capacity 36.3% and release kinetic similar to the Korsmeyer-Peppas model. Splenocytes of animals immunized with new microsphere-based whole-cell vaccine produced greater quantities of IFN-gamma and higher amounts of IL-4 and IL-5 cytokines compared to conventional adjuvant-adsorbed vaccines. Conventional adjuvant-adsorbed vaccines produced smaller quantities of IL-4 and IL-5. Bordetella pertussis entrapped microspheres induced both cell-mediated and humoral antibody in mice, evidenced by high levels of IgG2a and IgG1. IgG2a levels in mice were enhanced using the common aluminum phosphate-adsorbed B. pertussis whole-cell vaccine, and IgG1 levels did not increase significantly. Bordetella pertussis entrapped microspheres and common B. pertussis whole-cell vaccine samples enhanced total IgG levels in mice; however, B. pertussis-entrapped microspheres produced significantly higher levels of total IgG than other test samples. Conclusion: Encapsulation of inactive B. pertussis cells in microspheres appears to be a suitable approach for improving the wP vaccine quality, in particular by decreasing its toxicity to obtain good cell-mediated and humoral immunogenicity with a low bacterial number content.
引用
收藏
页码:585 / 593
页数:9
相关论文
共 50 条
  • [41] CELL-MEDIATED IMMUNE-RESPONSES OF GUINEA-PIGS TO AN INACTIVATED PHASE-I COXIELLA-BURNETII VACCINE
    KISHIMOTO, RA
    JOHNSON, JW
    KENYON, RH
    ASCHER, MS
    LARSON, EW
    PEDERSEN, CE
    INFECTION AND IMMUNITY, 1978, 19 (01) : 194 - 198
  • [42] DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
    Prompetchara, Eakachai
    Ketloy, Chutitorn
    Tharakhet, Kittipan
    Kaewpang, Papatsara
    Buranapraditkun, Supranee
    Techawiwattanaboon, Teerasit
    Sathean-anan-kun, Suwitra
    Pitakpolrat, Patrawadee
    Watcharaplueksadee, Supaporn
    Phumiamorn, Supaporn
    Wijagkanalan, Wassana
    Patarakul, Kanitha
    Palaga, Tanapat
    Ruxrungtham, Kiat
    PLOS ONE, 2021, 16 (03):
  • [43] SECRETORY AND SYSTEMIC CELL MEDIATED AND HUMORAL IMMUNE-RESPONSES, IN HUMANS AND GUINEA-PIGS, TO INACTIVATED INFLUENZA-VIRUS VACCINE
    WALDMAN, RH
    OLSEN, GN
    GADOL, N
    JURGENSEN, PF
    JOHNSON, JE
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (07): : 999 - +
  • [44] CELL-MEDIATED AND HUMORAL IMMUNE-RESPONSES AFTER VACCINATION OF HUMAN VOLUNTEERS WITH THE LIVE VACCINE STRAIN OF FRANCISELLA-TULARENSIS
    WAAG, DM
    MCKEE, KT
    SANDSTROM, G
    PRATT, LLK
    BOLT, CR
    ENGLAND, MJ
    NELSON, GO
    WILLIAMS, JC
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (02) : 143 - 148
  • [45] CELL-MEDIATED AND HUMORAL IMMUNE-RESPONSES INDUCED BY SCARIFICATION VACCINATION OF HUMAN VOLUNTEERS WITH A NEW LOT OF THE LIVE VACCINE STRAIN OF FRANCISELLA-TULARENSIS
    WAAG, DM
    GALLOWAY, A
    SANDSTROM, G
    BOLT, CR
    ENGLAND, MJ
    NELSON, GO
    WILLIAMS, JC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) : 2256 - 2264
  • [46] SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
    Bruminhent, Jackrapong
    Setthaudom, Chavachol
    Chaumdee, Pongsathon
    Boongird, Sarinya
    Kiertiburanakul, Sasisopin
    Malathum, Kumthorn
    Nongnuch, Arkom
    Phuphuakrat, Angsana
    Jirasiritham, Sopon
    Janphram, Chitimaporn
    Thotsiri, Sansanee
    Upama, Supparat
    Assanatham, Montira
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (03) : 813 - 822
  • [47] ENHANCEMENT OF CELL-MEDIATED IMMUNE RESPONSE IN MICE BY WHOLE HIV-1 GAG IN MYCOBACTERIUM BOVIS BCG AS A LIVE VACCINE CANDIDATE
    Promkhatkaew, Duanthanorm
    Pinyosukhee, Nadthanan
    Thongdeejaroen, Wilai
    Sutthent, Reungpung
    Sawanpanyalert, Pathom
    Warachit, Paijit
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2009, 40 (01) : 113 - 122
  • [48] 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine
    Arai, H
    Xin, KQ
    Hamajima, K
    Lu, Y
    Watabe, S
    Takahashi, T
    Toda, S
    Okuda, K
    Kudoh, I
    Suzuki, M
    Okuda, K
    GENE THERAPY, 2000, 7 (08) : 694 - 702
  • [49] 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine
    H Arai
    K-Q Xin
    K Hamajima
    Y Lu
    S Watabe
    T Takahashi
    S Toda
    K Okuda
    I Kudoh
    M Suzuki
    K Okuda
    Gene Therapy, 2000, 7 : 694 - 702
  • [50] Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults
    Giacomet, Vania
    Masetti, Michela
    Nannini, Pilar
    Forlanini, Federica
    Clerici, Mario
    Zuccotti, Gian Vincenzo
    Trabattoni, Daria
    PLOS ONE, 2018, 13 (02):